可换股债券
Search documents
紫金矿业拟发行于2031年到期的15亿美元零息有担保可换股债券
Zhi Tong Cai Jing· 2026-01-29 23:24
紫金矿业(601899)(02899)发布公告,于2026年1月29日(交易时段后),公司、发行人及经办人订立认 购协议。经办人同意在认购协议所载的条款及条件规限下,个别且并非共同地认购及支付或促使认购人 认购及支付发行人将予发行本金总额达15亿美元的债券,且公司已无条件及不可撤销地担保根据担保契 据的条款妥善准时支付信托契据及债券项下发行人明确应付的所有款项。 于条款及条件所载列的情况下,债券可按初始转换价每股H股63.30港元(可予调整)转换为H股。初始转 换价较于2026年1月29日(即签署认购协议的交易日)香港联交所所报每股H股最后收市价46.14港元溢价 约37.19%。 假设按初始转换价每股H股63.30港元悉数转换债券,债券将可转换为约1.85亿股H股,相当于本公告日 期的现有已发行H股数目约3.09%及现有已发行股份数目约0.70%,以及经于悉数转换债券后因发行转换 股份而扩大的已发行H股数目约2.99%及已发行股份数目约0.69%。转换股份将属缴足及在所有方面与于 相关登记日期当时已发行的H股享有同等地位。 待完成债券发行后,债券认购事项的所得款项净额(扣除经办人佣金及就此发售应付的其他估计 ...
中联重科拟发行60亿元于2031年到期的可换股债券
Zhi Tong Cai Jing· 2026-01-28 22:52
可换股债券可以依据其条款及条件所载的情况转换为H股,初始转股价格为每股H股港元10.02(可予调 整)。 假设可换股债券全部按每股H股10.02港元的初始转股价格进行转换,可换股债券将可转换为约6.73亿股 H股,约相当于(i)公司于本公告日期的已发行H股总数43.36%及已发行股本总数7.78%,以及(ii)公司于 可换股债券全数转换后经扩大的已发行H股总数30.25%及经扩大的已发行股本总数7.22%。转换股份将 属缴足及在所有方面与公司于相关登记日期时的已发行H股享有同等地位。 中联重科(000157)(01157)发布公告,2026年1月29日(交易时段前),公司与经办人订立《认购协 议》,据此,公司已经同意向经办人或按其指示发行可换股债券,而经办人已经各别(并非共同)同意按 《认购协议》若干条款,认购本金人民币60亿元(按固定汇率换算,约等同67.45亿港元)可换股债券并支 付其价款,或促使认购人认购可换股债券并支付其价款。 经办人于2026年1月28日(交易时段后)进行簿记建档后,厘定了可换股债券的最终条款,包括但不限于 本金额与初始转股价格。 ...
协鑫科技拟发行本金总额不超过11.7亿港元的可换股债券
Zhi Tong Cai Jing· 2026-01-28 14:59
Group 1 - The company GCL-Poly Energy Holdings Limited (03800) announced a subscription agreement for the issuance of convertible bonds with a total principal amount of up to HKD 1.17 billion [1] - The conversion price for the bonds is set at HKD 1.60 per share, which represents a premium of approximately 41.59% over the last closing price of HKD 1.130 [1] - Upon full conversion of the bonds, a total of 731 million shares will be issued, accounting for about 2.20% of the company's existing issued share capital and approximately 2.15% of the enlarged issued share capital [1] Group 2 - The proceeds from the issuance of the convertible bonds, estimated at around HKD 1.17 billion, are intended for investment in a merger and acquisition fund, which requires approval from both the company and the subscriber [1]
极兔速递-W:建议发行于2033年到期的零息有担保可换股债券
Zhi Tong Cai Jing· 2026-01-22 23:15
Group 1 - The company announced the issuance of HKD 4.65 billion convertible bonds due in 2026, with a subscription agreement signed on January 22, 2026 [1] - The initial conversion price of HKD 14.55 per share represents a premium of approximately 30.85% over the last closing price of HKD 11.12 on the Hong Kong Stock Exchange on the signing date [2] - The total net proceeds from the bond issuance, after deducting expenses, are expected to be approximately HKD 4.596 billion, which will be used for overseas business development, technology upgrades, optimizing capital structure, and general corporate purposes [2] Group 2 - The convertible bonds can be converted into a maximum of 320 million new shares, representing about 3.56% of the existing issued share capital as of the announcement date [2] - The new shares will not require shareholder approval and will rank equally with existing shares on the record date [2] - The net price per new share, assuming full conversion of the bonds, is estimated to be approximately HKD 14.38 [2]
永泰生物(06978) - 有关根据一般授权发行可换股债券的框架协议及票据
2026-01-20 14:43
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責,對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明,並 明 確 表 示,概 不 就 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 Immunotech Biopharm Ltd 永泰生物製藥有限公司 (於 開 曼 群 島 註 冊 成 立 的 有 限 公 司) (股 份 代 號:6978) 有關根據一般授權 發行可換股債券的框架協議 及票據 董 事 會 欣 然 宣 佈,本 公 司 與 投 資 者 就 認 購 新 可 換 股 債 券 及 票 據 訂 立 具 法 律 約 束 力 的 框 架 協 議。認 購 事 項 的 代 價 將 專 項 用 作 全 數 及 最 終 清 償 將 於2026 年2月20日到期的2023年 可 換 股 債 券 的 本 金 額。換 股 股 份 將 根 據 一 般 授 權 發 行,彼 此 之 間 及 與 轉 換 日 期 的 已 發 行 股 份 將 享 有 同 等 地 位。 本 公 司 與 投 資 者 現 正 進 行 磋 商,旨 在 儘 快 落 實 認 購 協 ...
贪玩:完成发行于2027年到期的4.68亿港元零息可换股债券
Zhi Tong Cai Jing· 2026-01-08 14:18
Core Viewpoint - The company, 贪玩 (09890), has successfully completed the issuance of convertible bonds amounting to HKD 468 million, with all preconditions for the subscription and placement agreement being met [1] Group 1 - The total principal amount of the convertible bonds issued is HKD 468 million [1] - The bonds have been allocated to subscribers, who are confirmed to be independent third parties of the company [1] - The issuance of the convertible bonds was completed on January 8, 2026 [1]
港股异动 | 环球新材国际(06616)再跌超10% 公司拟发行10亿港元可转债 优化公司资本结构
智通财经网· 2026-01-02 04:07
Group 1 - The core point of the article is that Global New Materials International (06616) experienced a significant stock decline, dropping over 10% in early trading after announcing a proposed issuance of convertible bonds totaling HKD 1 billion [1] - The proposed convertible bonds will have an initial conversion price of HKD 10.19 per share, allowing for the conversion into approximately 98.14 million shares, which represents about 7.92% of the existing issued shares [1] - The net proceeds of approximately HKD 981 million will primarily be used to supplement working capital, refinance existing debts, and for general corporate purposes [1] Group 2 - Guotai Junan Securities stated that this financing will optimize the company's capital structure and enhance cash flow stability [1] - The funds raised will provide solid financial support for the company's core product research and development, global market expansion, and industry chain integration [1] - This move is expected to further solidify the company's leading position in the global pearlescent materials sector [1]
大摩:料美图公司(01357)与阿里巴巴-W(09988)合作进一步深化 目标价15.7港元 评级“增持”
智通财经网· 2026-01-02 03:06
Group 1 - Morgan Stanley reported that Meitu Inc. has completed the issuance of convertible bonds worth $250 million to Alibaba Group [1] - If all convertible bonds are converted, Alibaba will hold 6.82% of Meitu's shares, becoming its third-largest shareholder [1] - The report views this development as positive news, anticipating that the collaboration between Meitu and Alibaba will deepen, particularly generating strong synergies in the e-commerce design sector [1] Group 2 - Morgan Stanley has set a target price of HKD 15.7 for Meitu and assigned an "Overweight" rating [1]
环球新材国际午前放量暴跌26% 近期宣布拟发行本金总额10亿港元可换股债券
Zhi Tong Cai Jing· 2025-12-31 03:56
Core Viewpoint - 环球新材国际 experienced a significant drop in stock price, falling over 26% during trading, attributed to the announcement of a proposed issuance of convertible bonds totaling HKD 1 billion [1] Group 1: Stock Performance - The stock price of 环球新材国际 hit a low of HKD 8.8 during trading, representing a decline of more than 26% from the previous closing price [1] - As of the report, the stock was down 10.44%, trading at HKD 9.78, with a trading volume of HKD 172 million [1] Group 2: Convertible Bonds Announcement - The company announced plans to issue convertible bonds with a total principal amount of HKD 1 billion [1] - The initial conversion price is set at HKD 10.19 per share, allowing for the conversion into approximately 98.14 million shares, which represents about 7.92% of the existing issued shares [1] - The company intends to apply for the listing of the convertible bonds on Vienna MTF and for the conversion shares on the Hong Kong Stock Exchange [1]
港股公告掘金 | 英矽智能开启招股 智汇矿业香港公开发售获5248.15倍认购
Zhi Tong Cai Jing· 2025-12-18 15:34
New IPOs - The largest biotech IPO in Hong Kong for 2025 is initiated by Insilico Medicine (03696), which boasts the fastest global progress in AI drug development [1] - Lin Qingxuan (02657) will conduct its IPO from December 18 to December 23, attracting cornerstone investors like Fidelity [1] - Woan Robotics (06600) is set to launch its IPO during the same period, with an expected listing date of December 30 [1] - Meilian Holdings (02671) and Wuyi Vision (06651) will also hold their IPOs from December 18 to December 23, both expected to list on December 30 [1] - Xun Ce (03317) will follow the same IPO schedule, with a listing anticipated on December 30 [1] - Zhihui Mining (02546) achieved a remarkable 5248.15 times subscription in its public offering, with a listing date of December 19 [1] - China National Airlines (00753) plans to invest in Shenzhen Airlines' equity financing, with Kunhang Investment, a state-owned entity, being shortlisted [1] - Sensetime-W (00020) intends to place 1.75 billion new Class B shares, aiming to raise approximately HKD 3.146 billion [1] - Fosun Pharma (02196) is enhancing its overseas innovative drug strategy by signing a cooperation and option agreement with Clavis Bio [1] - WuXi AppTec (02359) invested around EUR 30 million to acquire a 3.22% stake in a French biopharmaceutical fund [1] - Minhua Holdings (01999) plans to acquire 100% equity in the American soft furniture company Gainline Recline Intermediate Corp [1] Share Buybacks - Tencent Holdings (00700) repurchased 1.055 million shares for HKD 636 million on December 18 [2] - Xiaomi Group-W (01810) spent HKD 151 million to buy back 3.75 million shares on the same day [2] - COSCO Shipping Holdings (01919) repurchased 5.9 million shares for HKD 80.557 million [2] - Country Garden Services (06098) bought back 2.7 million shares for HKD 17.136 million [2] - Jiangsu Ninghu Expressway (00177) saw an increase of 52.862 million shares by Yunsong Capital [2]